Literature DB >> 28116090

Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1.

Marc Uemura¹, Faisal Fa'ak¹, Cara Haymaker¹, Natalie McQuail¹, Elizabeth Sirmans¹, Courtney W Hudgens², Lydia Barbara¹, Chantale Bernatchez¹, Jonathan L Curry², Patrick Hwu¹, Michael T Tetzlaff², Adi Diab¹.

Abstract

[This corrects the article DOI: 10.1186/s40425-016-0157-6.].

Entities: Disease Gene

Year: 2017 PMID： 28116090 PMCID： PMC5244590 DOI： 10.1186/s40425-017-0208-7

Source DB: PubMed Journal: J Immunother Cancer ISSN： 2051-1426 Impact factor: 13.751

Erratum

Unfortunately, after publication of this article [1], it was noticed that the name of the second author was incorrectly displayed as Faa’k Faisal. The correct name is Faisal Fa’ak and can be seen in the corrected author list above. The original article has also been updated to correct this error.

1 in total

1. A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1.

Authors: Marc Uemura; Faisal Fa'ak; Cara Haymaker; Natalie McQuail; Elizabeth Sirmans; Courtney W Hudgens; Lydia Barbara; Chantale Bernatchez; Jonathan L Curry; Patrick Hwu; Michael T Tetzlaff; Adi Diab
Journal: J Immunother Cancer Date: 2016-09-20 Impact factor: 13.751

1 in total

2 in total

Review 1. Checkpoint Inhibitors.

Authors: Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal: Dtsch Arztebl Int Date: 2019-02-22 Impact factor: 5.594

Review 2. Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review).

Authors: Guangshun Sun; Hanyuan Liu; Xuesong Shi; Pengyu Tan; Weiwei Tang; Xin Chen; Guoqiang Sun; Weijun Yang; Xiangyi Kong; Zhiying Zheng; Hongyong Cao; Guoqiang Shao
Journal: Int J Oncol Date: 2022-04-29 Impact factor: 5.884

2 in total